Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Mitral Incompetence

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Mitral Incompetence in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Montastruc, F1
Montastruc, G1
Vigreux, P1
Bruneval, P1
Guilbeau-Frugier, C1
Cron, C1
Bagheri, H1
Delisle, B1
Lapeyre-Mestre, M1
Pathak, A1
Montastruc, JL1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Mitral Incompetence

ArticleYear
Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').
    British journal of clinical pharmacology, 2012, Volume: 74, Issue:3

    Topics: Adult; Hallucinogens; Humans; Male; Mitral Valve Insufficiency; N-Methyl-3,4-methylenedioxyamphetami

2012